6 days ago · Partnering to Advance Human Health. Providing a range of contract pharmaceutical development and manufacturing services globally.

A privately owned organisation, Almac has grown organically over the past five decades, employing over 7,500 highly skilled employees across 18 facilities in Europe, North America, and Asia. Learn more about us here.

The Almac Gateway provides access to many of the online services provided by Almac. For more information on some of these services, see "What does the Almac Gateway offer" below, or for a full list of service offerings, please reach out to your Almac contact.

The Almac Group was founded by Allen McClay OBE, CBE and Galen Holdings PLC announced that it had agreed to sell its API Manufacturing and Chemical Development, Clinical Trial Supply and Clinical Technologies businesses to Almac

State-of-the-art US based labs support drug substance (API) and drug product (finished product) analytics across all phases of clinical development and into commercial release.

Almac’s continuous flow technology platform enables access to better synthetic strategies

Almac Clinical Technologies group has been leading the Interactive Response Technology (IRT) industry, bringing together the most innovative technology and our unparalleled expertise to empower biopharmaceutical industry and help bring new therapies to patients.

Almac Pharma Services provide a wide range of customised commercial services from supporting product launch, manufacturing and / or packaging drug product, to securing supply chain with global serialisation solutions.

The platforms we use for DNA analysis are suitable for diagnostic delivery and we have a number of CLIA validated assays available, such as the Cobas® KRAS, BRAF and EGFR. Almac has also developed our own CLIA validated next generation sequencing assay for the TP53 oncogene.

The Almac Group offers a highly specialised, personalised and expert service along each stage of the drug development lifecycle and beyond. Our innovative services range from R&D, biomarker discovery development and commercialisation through to product sales. Our areas of specialism are: † Drug Discovery † Diagnostic Services